• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCB1 4036A>G 和 1236C>T 多态性影响南非 HIV/AIDS 患者的血浆依非韦伦水平。

ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.

机构信息

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town Observatory, Cape Town, South Africa.

出版信息

Front Genet. 2012 Nov 5;3:236. doi: 10.3389/fgene.2012.00236. eCollection 2012.

DOI:10.3389/fgene.2012.00236
PMID:23133441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3488761/
Abstract

The ABCB1 gene encodes P-glycoprotein, an ATP-dependent drug efflux pump, which is responsible for drug transport across extra- and intra-cellular membranes. The variability in the expression of ABCB1 may contribute to variable plasma efavirenz concentration which results in variability in the levels of suppression of the human immunodeficiency syndrome virus (HIV). The aim of the study was to evaluate the role of polymorphisms in ABCB1 gene on plasma efavirenz levels and treatment response in the form of change in viral load and CD-4 cell count in HIV/AIDS patients receiving efavirenz-containing highly active antiretroviral treatment regimens. Two hundred and eighty-two HIV-infected patients were recruited from Themba Lethu Clinic in Johannesburg and plasma efavirenz drug concentration levels were measured using LC-MS/MS. SNaPshot was used to genotype five known ABCB1 single nucleotide polymorphisms (SNPs). Genotype-phenotype correlations were computed. The ABCB1 4036A/G and 4036G/G genotypes were significantly associated with low plasma efavirenz concentrations (P = 0.0236), while the ABCB1 1236C/T and 1236T/T genotypes were associated with high efavirenz concentrations (P = 0.0282). A haplotype ABCB1 T-G-T-A is reported that is associated with significantly increased plasma efavirenz levels. This is the first report on 61A>G, 2677G>T/A, and 4036A>G SNPs in the South African population. ABCB1 plays a role in determining the plasma concentrations of efavirenz and should be taken into account in future design of assays for genotype-based dosing of efavirenz-containing regimens.

摘要

ABCB1 基因编码 P-糖蛋白,一种 ATP 依赖性药物外排泵,负责将药物跨细胞内外膜转运。ABCB1 的表达变异性可能导致依非韦伦的血浆浓度变化,从而导致人类免疫缺陷病毒 (HIV) 的抑制水平变化。本研究旨在评估 ABCB1 基因多态性对接受依非韦伦为基础的高效抗逆转录病毒治疗方案的 HIV/AIDS 患者的血浆依非韦伦水平和治疗反应(以病毒载量和 CD4 细胞计数的变化形式)的作用。从约翰内斯堡 Themba Lethu 诊所招募了 282 名 HIV 感染患者,并使用 LC-MS/MS 测量血浆依非韦伦药物浓度水平。SNaPshot 用于检测五个已知的 ABCB1 单核苷酸多态性(SNP)的基因型。计算了基因型-表型相关性。ABCB1 4036A/G 和 4036G/G 基因型与低血浆依非韦伦浓度显著相关(P=0.0236),而 ABCB1 1236C/T 和 1236T/T 基因型与高依非韦伦浓度相关(P=0.0282)。报道了一种 ABCB1 T-G-T-A 单倍型,与血浆依非韦伦水平显著升高相关。这是南非人群中首次报道 61A>G、2677G>T/A 和 4036A>G SNP。ABCB1 在外排依非韦伦中起作用,在未来设计基于基因型的依非韦伦剂量测定的测定方法时应考虑到这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/4ea6479a5816/fgene-03-00236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/d38cdb3a3349/fgene-03-00236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/ef7da9973cab/fgene-03-00236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/4ea6479a5816/fgene-03-00236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/d38cdb3a3349/fgene-03-00236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/ef7da9973cab/fgene-03-00236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/3488761/4ea6479a5816/fgene-03-00236-g003.jpg

相似文献

1
ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.ABCB1 4036A>G 和 1236C>T 多态性影响南非 HIV/AIDS 患者的血浆依非韦伦水平。
Front Genet. 2012 Nov 5;3:236. doi: 10.3389/fgene.2012.00236. eCollection 2012.
2
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics.阿片转运蛋白1(ABCB1)单倍型与μ-阿片受体基因(OPRM1)118A>G基因型在美沙酮维持治疗药物遗传学中的相互作用
Pharmgenomics Pers Med. 2012;5:53-62. doi: 10.2147/PGPM.S29272. Epub 2012 Apr 18.
3
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.人类ABCB1基因中与种族相关的多态性和单倍型
Pharmacogenomics. 2007 Jan;8(1):29-39. doi: 10.2217/14622416.8.1.29.
4
ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染男性中ABCB1基因多态性与洛匹那韦和利托那韦在血液、精液及唾液中的浓度
Pharmacogenomics. 2009 Feb;10(2):311-8. doi: 10.2217/14622416.10.2.311.
5
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.多位点基因相互作用与含依非韦伦治疗方案的反应:一项成人艾滋病临床试验组研究。
Pharmacogenet Genomics. 2006 Nov;16(11):837-45. doi: 10.1097/01.fpc.0000230413.97596.fa.
6
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.ABCB1 基因多态性对瑞伐沙班在 HEK293 重组细胞系中转运的影响。
Sci Rep. 2018 Jul 12;8(1):10514. doi: 10.1038/s41598-018-28622-4.
7
ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.ABCB1基因多态性与冷压痛反应:接受美沙酮维持治疗的阿片类药物依赖患者。
Nurs Res. 2017 Mar/Apr;66(2):134-144. doi: 10.1097/NNR.0000000000000204.
8
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.细胞色素2B6基因多态性与依非韦伦所致中枢神经系统症状:ANRS ALIZE试验的一项子研究
HIV Med. 2017 Sep;18(8):537-545. doi: 10.1111/hiv.12488. Epub 2017 Feb 1.
9
Efavirenz pharmacogenetics in a cohort of Italian patients.一组意大利患者中的依非韦伦药物遗传学
Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 Dec 18.
10
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.CYP3A 和 ABCB1 单核苷酸多态性对钙调神经磷酸酶抑制剂的药代动力学和药效学的影响:第一部分。
Clin Pharmacokinet. 2010 Mar;49(3):141-75. doi: 10.2165/11317350-000000000-00000.

引用本文的文献

1
Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic review.多替拉韦药代动力学的遗传变异及其与安全性和疗效结果的关系:一项系统评价
Pharmacogenomics. 2024;25(14-15):623-635. doi: 10.1080/14622416.2024.2441104. Epub 2024 Dec 19.
2
Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases.迈向南部非洲基于证据的药物基因组学实施:跨疾病的合并症和多药治疗情况
J Pers Med. 2023 Jul 26;13(8):1185. doi: 10.3390/jpm13081185.
3
Expression of Enzyme in Human Liver Tissue of HIV and HCV Patients.

本文引用的文献

1
Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.在南非黑人人群中,CYP(-1A2、-2C9、-2C19、-3A4 和-3A5)、VKORC1 和 ABCB1 基因中的遗传变异:多样性的窗口。
Pharmacogenomics. 2011 Dec;12(12):1663-70. doi: 10.2217/pgs.11.106.
2
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.探讨马拉维人体内 CYP450 和药物转运体基因型与奈韦拉平暴露的关系。
Pharmacogenomics. 2012 Jan;13(1):113-21. doi: 10.2217/pgs.11.132. Epub 2011 Nov 23.
3
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
HIV 和 HCV 患者肝组织中酶的表达。
Medicina (Kaunas). 2023 Jun 27;59(7):1207. doi: 10.3390/medicina59071207.
4
Genetic and non-genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus-1-infected children in Ethiopia.遗传和非遗传因素对埃塞俄比亚人类免疫缺陷病毒-1 感染儿童中依非韦伦群体药代动力学的影响。
CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):783-794. doi: 10.1002/psp4.12951. Epub 2023 Mar 23.
5
Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.用于HIV长效暴露前预防的抗逆转录病毒药物转运体的药物基因组学
Front Genet. 2022 Sep 29;13:940661. doi: 10.3389/fgene.2022.940661. eCollection 2022.
6
and Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study.基因型预测长期接受基于依非韦伦的抗逆转录病毒治疗的HIV患者的葡萄糖代谢紊乱:一项病例对照研究。
J Pers Med. 2022 Jun 30;12(7):1087. doi: 10.3390/jpm12071087.
7
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.乳腺癌治疗的药物遗传学:撒哈拉以南非洲视角
Pharmgenomics Pers Med. 2022 Jun 21;15:613-652. doi: 10.2147/PGPM.S308531. eCollection 2022.
8
Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study.中国类风湿关节炎患者转运体基因多态性与甲氨蝶呤临床反应的相关性:一项初步研究。
Pharmgenomics Pers Med. 2022 Apr 12;15:327-339. doi: 10.2147/PGPM.S350417. eCollection 2022.
9
Predictors of Efavirenz Plasma Exposure, Auto-Induction Profile, and Effect of Pharmacogenetic Variations among HIV-Infected Children in Ethiopia: A Prospective Cohort Study.埃塞俄比亚HIV感染儿童中依非韦伦血浆暴露量、自身诱导情况及药物遗传学变异影响的预测因素:一项前瞻性队列研究
J Pers Med. 2021 Dec 5;11(12):1303. doi: 10.3390/jpm11121303.
10
Assessment of the Interaction Potential of (L.) Extracts on CYP2B6, 3A4, and Rifampicin Metabolism.(L.)提取物对CYP2B6、3A4及利福平代谢的相互作用潜力评估。
Front Pharmacol. 2020 Apr 30;11:517. doi: 10.3389/fphar.2020.00517. eCollection 2020.
细胞色素 P450 2B6(CYP2B6)和组成型雄烷受体(CAR)多态性与依非韦伦为基础方案的早期停药有关。
J Antimicrob Chemother. 2011 Sep;66(9):2092-8. doi: 10.1093/jac/dkr272. Epub 2011 Jun 29.
4
Analysis of pharmacogenetic traits in two distinct South African populations.分析两个不同南非人群中的遗传药理学特征。
Hum Genomics. 2011 May;5(4):265-82. doi: 10.1186/1479-7364-5-4-265.
5
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.抗 HIV 一线治疗药物过早停药与药物遗传学标记物的相关性:一项观察性队列研究。
J Infect Dis. 2011 Jan 15;203(2):246-57. doi: 10.1093/infdis/jiq043. Epub 2010 Dec 9.
6
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.一种新的 ABCB1 基因、CYP2B6*6 和性别多态性可预测乌干达人体内单剂量依非韦伦的群体药代动力学。
Br J Clin Pharmacol. 2009 Nov;68(5):690-9. doi: 10.1111/j.1365-2125.2009.03516.x.
7
ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan.ABCB1、SLCO1B1和UGT1A1基因多态性与一线伊立替康治疗的转移性结直肠癌患者的毒性相关。
Drug Metab Lett. 2007 Jan;1(1):23-30. doi: 10.2174/187231207779814328.
8
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.常见多药耐药基因1(ABCB1)单倍型中的同义多态性影响蛋白质功能。
Biochim Biophys Acta. 2009 May;1794(5):860-71. doi: 10.1016/j.bbapap.2009.02.014. Epub 2009 Mar 11.
9
Substrate-dependent effects of human ABCB1 coding polymorphisms.人类ABCB1编码多态性的底物依赖性效应。
J Pharmacol Exp Ther. 2008 May;325(2):435-42. doi: 10.1124/jpet.107.135194. Epub 2008 Feb 20.
10
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.多位点基因相互作用与含依非韦伦治疗方案的反应:一项成人艾滋病临床试验组研究。
Pharmacogenet Genomics. 2006 Nov;16(11):837-45. doi: 10.1097/01.fpc.0000230413.97596.fa.